Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |